Implementation explainer: Pharmacovigilance
Download this document free
Get this document with your free trial. Choose from the full Complyzard library.
Try 1 month free30 days free, then $19/month. Trial terms apply. Card required. Cancel anytime.Document information
Explainer for the pharmaceutical industry on the implementation of Pharmacovigilance requirements during the transition time from the date the revised VMR have effect in GB to 17 May 2027.
Adapted edition
- Document type
- Reference Guide
- Format
- DOCX
- Pages
- 4
- Language
- English
- Version
- 1.0
- Updated
- 2026-09-16
- Category
- Safety & operations
- Licence
- Open Government Licence v3.0
Description
Explainer for the pharmaceutical industry on the implementation of Pharmacovigilance requirements during the transition time from the date the revised VMR have effect in GB to 17 May 2027. Consult the original guidance for current legal and operational details.
Contents
- Veterinary Medicines Regulations implementation from 17 May 2024
- Adverse event reporting
- Northern Ireland reports
- Third country reports
- Format of the reports
- Adverse event report reference number
- Signal Management and Annual Benefit Risk Reporting
- PSMF
Source and licence
Veterinary Medicines Directorate
AttributionVeterinary Medicines Directorate, ‘Implementation explainer: Pharmacovigilance’ (updated 10 July 2026), reused under the Open Government Licence v3.0.
ChangesNeutral text-only adaptation from the official GOV.UK Content API body: headings, paragraphs, ordered and unordered list items and clickable source-link destinations in an appendix preserved. Images, logos, page design, accessible-format request widgets and linked attachments excluded; normalised whitespace, invisible format marks and typography.
Version history
- v1.016/09/2026